Literature DB >> 1916093

Staphylococcal enterotoxin microbial superantigens.

H M Johnson1, J K Russell, C H Pontzer.   

Abstract

Staphylococcal enterotoxins are a family of structurally related proteins that are produced by Staphylococcus aureus. In addition to their role in the pathogenicity of food poisoning, these microbial superantigens have profound effects on the immune system, which makes them useful tools for understanding its mechanism of action. These molecules (24-30 kDa) are highly hydrophilic and exhibit low alpha helix and high beta pleated sheet content, suggesting a flexible, accessible structure. Staphylococcal enterotoxins are among the most potent activators of T lymphocytes known. The receptors for staphylococcal enterotoxins on antigen-presenting cells are major histocompatibility complex (MHC) class II molecules. Further, the alpha-helical regions of the class II molecule are essential for function and appear to interact directly with the NH2-terminal region of staphylococcal enterotoxins such as SEA. Recent studies have shown that a complex of staphylococcal enterotoxin and MHC class II molecules is required for binding to the V beta region of the T cell antigen receptor. Staphylococcal enterotoxin mitogenic activity is dependent on induction of interleukin 2, which may be intimately involved in the mechanism of toxicity. The mouse minor lymphocyte stimulating (M1s) "endogenous" self-superantigen has been shown to be a retroviral gene product, so this too is apparently a microbial superantigen. An understanding of the mechanisms of action of these microbial superantigens has implications for normal and pathological immune functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916093     DOI: 10.1096/fasebj.5.12.1916093

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  32 in total

1.  Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity.

Authors:  Glen C Ulett; Elisabeth E Adderson
Journal:  Curr Immunol Rev       Date:  2006-05

2.  Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.

Authors:  J Tseng; J L Komisar; R N Trout; R E Hunt; J Y Chen; A J Johnson; L Pitt; D L Ruble
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

3.  Staphylococcal enterotoxin B primes cytokine secretion and lytic activity in response to native bacterial antigens.

Authors:  K M Mason; T D Dryden; N J Bigley; P S Fink
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

Review 4.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

5.  Interleukin-8 (IL-8) is a major neutrophil chemotaxin from human alveolar macrophages stimulated with staphylococcal enterotoxin A (SEA).

Authors:  E J Miller; S Nagao; F K Carr; J M Noble; A B Cohen
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

6.  Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.

Authors:  J M Soos; A C Hobeika; E J Butfiloski; J Schiffenbauer; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

7.  Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model.

Authors:  B E Barton; J Shortall; J V Jackson
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  A novel approach for cancer immunotherapy: tumor cells with anchored superantigen SEA generate effective antitumor immunity.

Authors:  Wenxue Ma; Hai Yu; Qingqing Wang; Hongchuan Jin; Joyce Solheim; Vinod Labhasetwar
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

9.  Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.

Authors:  T O Harris; D Grossman; J W Kappler; P Marrack; R R Rich; M J Betley
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

Authors:  M Dohlsten; L Abrahmsén; P Björk; P A Lando; G Hedlund; G Forsberg; T Brodin; N R Gascoigne; C Förberg; P Lind
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.